<?xml version="1.0" encoding="UTF-8"?>
<p>Such men present with a clinically defined favourable metastatic burden and are hypothesised to occupy an intermediate state between ‘locally advanced’ and ‘poly-metastatic’ disease.
 <xref rid="R10" ref-type="bibr">10 11</xref> It is postulated, but not proven, that men exhibiting such disease patterns gain most benefit in progression-free survival (PFS) and OS resulting from localised cancer control achieved via cytoreductive interventions.
 <xref rid="R2" ref-type="bibr">2 10</xref>
</p>
